…16, 45.6% at W20, 44.3% at W24, and 56.4% at W52 with continued mirikizumab SC treatment, while CDAI clinical remission and PRO clinical re…
4articles mentioning drugs
14drug mentions
1distinct drugs extracted
0%of mentions human-reviewed
Active filtersEntity: Mirikizumab ×
Mirikizumab
This drug is selected. Its supporting articles are shown below.
Articles mentioning Mirikizumab
4 articles · page 1 of 1mirikizumabCrohn’s disease
99.1%
mirikizumabustekinumabulcerative colitisItalian inflammatory bowel disease centers
…Objective To evaluate the effectiveness and safety of mirikizumab in patients with ulcerative colitis in clinical practice.Method…
MirikizumabMIRICrohn’s disease
…I=Crohn’s Disease Activity Index; CSF=corticosteroid free; MIRI=Mirikizumab; mNRI=Modified Nonresponder Imputation; N=Number of Patients in…
Mirikizumabulcerative colitis
…Mirikizumab has expanded the therapeutic landscape for moderate-to-severe u…